Nuclivision (Series A)

Funding Details
Awarder
RSS - tech.eu
Date Award
April 28, 2025
Vertical
Healthtech
Funding URL
View Funding Page

Company Info
Founding Year
2022
Traction
The company is in the final phase of regulatory approval and plans to launch its product in the European market.
Company Description
Nuclivision provides novel radiotracers and treatments for oncology to help patients by improving the safety of nuclear medicine.
Market
Medical Imaging
Location
Ghent, Belgium
Coinvestors
LUMO Labs, Heran Partners, imec.istart future fund

Links
Back to Home Back to Healthtech Deals View Funding Announcement